Cargando…

An accelerated shift in the use of remote systems in epilepsy due to the COVID-19 pandemic

PURPOSE: The purpose of the study was to describe epileptologists' opinion on the increased use of remote systems implemented during the COVID-19 pandemic across clinics, education, and scientific meetings activities. METHODS: Between April and May 2020, we conducted a cross-sectional, electron...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuchenbuch, Mathieu, D'Onofrio, Gianluca, Wirrell, Elaine, Jiang, Yuwu, Dupont, Sophie, Grinspan, Zachary M., Auvin, Stephane, Wilmshurst, Jo M., Arzimanoglou, Alexis, Cross, J. Helen, Specchio, Nicola, Nabbout, Rima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457939/ https://www.ncbi.nlm.nih.gov/pubmed/32882627 http://dx.doi.org/10.1016/j.yebeh.2020.107376

Ejemplares similares

3D figure of epilepsy syndromes
por: Nabbout, Rima, et al.
Publicado: (2022)

Care Delivery for Children With Epilepsy During the COVID-19 Pandemic: An International Survey of Clinicians
por: Wirrell, Elaine C., et al.
Publicado: (2020)

Add‐on cannabidiol significantly decreases seizures in 3 patients with SYNGAP1 developmental and epileptic encephalopathy
por: Kuchenbuch, Mathieu, et al.
Publicado: (2020)

Medical treatment in infants and young children with epilepsy: Off‐label use of antiseizure medications. Survey Report of ILAE Task Force Medical Therapies in Children
por: Sourbron, Jo, et al.
Publicado: (2022)

Physician and patient satisfaction with the switch to remote outpatient encounters in epilepsy clinics during the Covid-19 pandemic
por: Teng, T., et al.
Publicado: (2021)

International consensus on diagnosis and management of Dravet syndrome
por: Wirrell, Elaine C., et al.
Publicado: (2022)

Slow Titration of Cannabidiol Add-On in Drug-Resistant Epilepsies Can Improve Safety With Maintained Efficacy in an Open-Label Study
por: D'Onofrio, Gianluca, et al.
Publicado: (2020)

Expert Opinion on the Management of Lennox–Gastaut Syndrome: Treatment Algorithms and Practical Considerations
por: Cross, J. Helen, et al.
Publicado: (2017)

Improving early diagnosis of rare diseases using Natural Language Processing in unstructured medical records: an illustration from Dravet syndrome
por: Barco, Tommaso Lo, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on the care of rare and undiagnosed diseases patients in France: a longitudinal population-based study
por: Soussand, Louis, et al.
Publicado: (2022)

Epilepsy with migrating focal seizures: KCNT1 mutation hotspots and phenotype variability
por: Barcia, Giulia, et al.
Publicado: (2019)

Novel study design to assess the efficacy and tolerability of antiseizure medications for focal‐onset seizures in infants and young children: A consensus document from the regulatory task force and the pediatric commission of the International League against Epilepsy (ILAE), in collaboration with the Pediatric Epilepsy Research Consortium (PERC)
por: Auvin, Stéphane, et al.
Publicado: (2019)

Dravet Syndrome as an Example of Precision Medicine in Epilepsy
por: Sullivan, Joseph, et al.
Publicado: (2022)

Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical Trial
por: Nabbout, Rima, et al.
Publicado: (2020)

Temporal Lobe Epilepsy in Children
por: Nickels, Katherine C., et al.
Publicado: (2012)

Advocacy for children with epilepsy: Leveraging the WHA resolution. Advocacy Task Force, Commission of Pediatrics, International League Against Epilepsy
por: Wilmshurst, Jo M., et al.
Publicado: (2018)

Monogenic Epilepsies: Disease Mechanisms, Clinical Phenotypes, and Targeted Therapies
por: Guerrini, Renzo, et al.
Publicado: (2021)

Greater Response to Placebo in Children Than in Adults: A Systematic Review and Meta-Analysis in Drug-Resistant Partial Epilepsy
por: Rheims, Sylvain, et al.
Publicado: (2008)

Treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy
por: Auvin, Stéphane
Publicado: (2007)

Whole‐exome and HLA sequencing in Febrile infection‐related epilepsy syndrome
por: Helbig, Ingo, et al.
Publicado: (2020)

New developments for dietary treatment of epilepsy after a century of history for the ketogenic diet
por: Auvin, Stéphane
Publicado: (2021)

Proposal to optimize evaluation and treatment of Febrile infection‐related epilepsy syndrome (FIRES): A Report from FIRES workshop
por: Koh, Sookyong, et al.
Publicado: (2021)

Validating Coding for the Identification of Pediatric Treatment Resistant Epilepsy Patients
por: Freedman, Daniel A., et al.
Publicado: (2021)

Mutations and Deletions in PCDH19 Account for Various Familial or Isolated Epilepsies in Females
por: Depienne, Christel, et al.
Publicado: (2011)

COVID-19 in Patients With Seizures and Epilepsy: Interpretation of Relevant Knowledge of Presenting Signs and Symptoms
por: Hogan, Robert Edward, et al.
Publicado: (2020)

Fatal Status Epilepticus in Dravet Syndrome
por: De Liso, Paola, et al.
Publicado: (2020)

Reply to Dravet, C. Different Outcomes of Acute Encephalopathy after Status Epilepticus in Patients with Dravet Syndrome. How to Avoid Them? Comment on “De Liso et al. Fatal Status Epilepticus in Dravet Syndrome. Brain Sci. 2020, 10, 889”
por: De Liso, Paola, et al.
Publicado: (2021)

A real‐life pilot study of the clinical application of pharmacogenomics testing on saliva in epilepsy
por: Riva, Antonella, et al.
Publicado: (2023)

International consensus recommendations for management of new onset refractory status epilepticus including febrile infection‐related epilepsy syndrome: Statements and supporting evidence
por: Wickstrom, Ronny, et al.
Publicado: (2022)

Measuring Health-Related Quality of Life in Tuberous Sclerosis Complex – Psychometric Evaluation of Three Instruments in Individuals With Refractory Epilepsy
por: de Vries, Petrus J., et al.
Publicado: (2018)

Long-term safety and effectiveness of zonisamide in the treatment of epilepsy: a review of the literature
por: Zaccara, Gaetano, et al.
Publicado: (2009)

Impact of the COVID‐19 lockdown on patients and families with Dravet syndrome
por: Brambilla, Isabella, et al.
Publicado: (2021)

International consensus recommendations for management of new onset refractory status epilepticus (NORSE) including febrile infection‐related epilepsy syndrome (FIRES): Summary and clinical tools
por: Wickström, Ronny, et al.
Publicado: (2022)

EPINETLAB: A Software for Seizure-Onset Zone Identification From Intracranial EEG Signal in Epilepsy
por: Quitadamo, Lucia R., et al.
Publicado: (2018)

Comparison of Laboratory and Field Remote Sensing Methods to Measure Forage Quality
por: Guo, Xulin, et al.
Publicado: (2010)

Encephalopathy in children with Dravet syndrome is not a pure consequence of epilepsy
por: Nabbout, Rima, et al.
Publicado: (2013)

Cognitive consequences of early versus late antiepileptic drug withdrawal after pediatric epilepsy surgery, the TimeToStop (TTS) trial: study protocol for a randomized controlled trial
por: Boshuisen, Kim, et al.
Publicado: (2015)

Cannabidiol Treatment for Refractory Epilepsies in Pediatrics
por: Raucci, Umberto, et al.
Publicado: (2020)

Importance of access to epilepsy monitoring units during the COVID-19 pandemic: Consensus statement of the International League against epilepsy and the International Federation of Clinical Neurophysiology()
por: Beniczky, Sándor, et al.
Publicado: (2021)

Remote Shifting at the CLEO Experiment
por: Wilksen, T, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_n3o2l5hpsq5ald0tujoee07i4i